Radical‐induced oxidation of metformin

Metformin (1,1‐dimethylbiguanide) is an antihyperglycaemic drug used to normalize glucose concentrations in type 2 diabetes. Furthermore, antioxidant benefits have been reported in diabetic patients treated with metformin. This work was aimed at studying the scavenging capacity of this drug against...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of biochemistry Vol. 271; no. 23‐24; pp. 4745 - 4752
Main Authors Khouri, H., Collin, F., Bonnefont‐Rousselot, D., Legrand, A., Jore, D., Gardès‐Albert, M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.12.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Metformin (1,1‐dimethylbiguanide) is an antihyperglycaemic drug used to normalize glucose concentrations in type 2 diabetes. Furthermore, antioxidant benefits have been reported in diabetic patients treated with metformin. This work was aimed at studying the scavenging capacity of this drug against reactive oxygen species (ROS) like ·OH and ‐free radicals. ROS were produced by gamma radiolysis of water. The irradiated solutions of metformin were analyzed by UV/visible absorption spectrophotometry. It has been shown that hydroxyl free radicals react with metformin in a concentration‐dependent way. The maximum scavenging activity was obtained for concentrations of metformin ≥ 200 µmol·L−1, under our experimental conditions. An estimated value of 107 L·mol−1·s−1 has been determined for the second order rate constant k(·OH + metformin). Superoxide free radicals and hydrogen peroxide do not initiate any oxidation on metformin in our in vitro experiments.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-2956
1432-1033
DOI:10.1111/j.1432-1033.2004.04438.x